Fig. 3From: Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunityAge is associated with higher frequency, earlier onset and increased severity of therapy-induced hepatitis. A Pie charts depicting the percentage of patients with therapy-induced hepatitis. B Kaplan–Meier analysis of hepatitis events in young patients (< 55, n = 21) and aged patients (≥ 55, n = 18). C Dot plot describing the age of patients without hepatitis, or who developed mild hepatitis (CTC-AE 1–2) or severe hepatitis (CTC-AE 3–4) Statistics were performed by log-rank test (B) and Kruskal–Wallis test (C)Back to article page